The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence From Two Recent Genetic Endocannabinoid Deficiency Models.

Biol Psychiatry

Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt Brain Institute, Vanderbilt University School of Medicine, Nashville, Tennessee; Vanderbilt-Kennedy Center for Research on Human Development, Vanderbilt University School of Medicine, Nashville, Tennessee.

Published: May 2016

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.biopsych.2015.04.028	DOI Listing

Publication Analysis

anxiolytic actions

actions 2-arachidonoylglycerol

2-arachidonoylglycerol converging

converging evidence

evidence genetic

genetic endocannabinoid

endocannabinoid deficiency

deficiency models

anxiolytic

2-arachidonoylglycerol

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!